author-photo

Aiman Shalabi

GlaxoSmithKline

2

Papers

0

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Master protocol to assess safety and recommended phase 2 dose of next generation NY-ESO-1–specific TCR T-cells in HLA-A*02 patients with synovial sarcoma or non-small cell lung cancer (Substudies 1 and 2).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+ patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)